New migraine drug

For Your Health

New research shows an experimental drug improved migraine pain symptoms in more people who got the drug than those who got the placebo.

(NBC NEWS) — An experimental drug is showing promise in the treatment of migraines.

Nearly 1,700 patients were involved in the phase 3 study.

Among those who were given the drug Ubrogepant, nearly 22-percent were free of migraine pain symptoms two hours later.

That is compared to the 14-percent who were on the placebo.

An FDA decision on approval is expected next month.

Copyright 2020 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Video Forecast

More Forecast

Don't Miss